Related Experiment Video
Updated: Jun 11, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance
Ming Shao1,2, Yunran Gao3, Xiling Xu3
1Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.
Exosomes drive ovarian cancer metastasis and drug resistance by altering the tumor microenvironment. Targeting these exosome-mediated pathways offers new therapeutic strategies for ovarian cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Ovarian cancer is a leading cause of gynecological cancer death.
- Peritoneal metastasis and drug resistance are major challenges in ovarian cancer treatment.
Purpose of the Study:
- This review focuses on the molecular mechanisms of exosome-mediated peritoneal metastasis and drug resistance in ovarian cancer.
- To explore exosome-driven processes within the tumor microenvironment.
Main Methods:
- Review of literature on exosome function in ovarian cancer.
- Analysis of exosome-mediated signaling pathways involved in metastasis and drug resistance.
Main Results:
- Exosomes promote peritoneal metastasis via epithelial-mesenchymal transition, extracellular matrix remodeling, and angiogenesis.
- Exosomes contribute to drug resistance by sequestering chemotherapy drugs, transferring resistance genes, and modulating DNA repair and apoptosis.
Conclusions:
- Exosomes play a critical role in ovarian cancer progression and therapeutic challenges.
- Exosomal pathways represent promising novel therapeutic targets for ovarian cancer intervention.
More Related Videos
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers

